Increasing Biopharmaceutical Manufacturing Downstream Process Efficiencies

By Tristan Passeggiati, executive account manager at Asahi Kasei Bioprocess

In large-scale biopharmaceutical manufacturing, downstream processing can represent a staggering 80% of total production costs. Even minor adjustments in these processes can lead to significant savings, potentially amounting to thousands of hours and millions of dollars. Optimizing efficiency is therefore paramount. Key strategies involve maximizing facility space through advanced machinery like innovative column packing and inline buffer formulation systems.

By smartly utilizing space, manufacturers can boost production capacity for large batches or diversify to handle smaller, custom orders, meeting the rising demand for varied biopharmaceuticals. Discover how optimizing space is just the first step towards major downstream savings.